PROTECTING YOUR RIGHT TO MEDICINES AND MEDICAL DEVICES
Thursday, 15 November 2018
enaffrdejaptxhzu

Project List

Cohort Event Monitoring of Artemisinin combination therapies (ACTs)

Malaria is a leading cause of mortality and morbidity in Zimbabwe. Due to the increase in cases of resistance to anti-malarials such as chloroquine, the World Health Organisation (WHO) and the Ministry of Health and Child Welfare (of Zimbabwe) is now promoting the use of artemisinin combination therapies (ACTs) for the treatment of uncomplicated acute falciparum malaria. Although ACTs are known to be safe and effective, their safety under large-scale operational use has not been fully assessed particularly among children and pregnant women. This project aims to assess the safety of ACTs among the Zimbabwean population.

Cohort Event Monitoring is a method where information is collected, with focus on events, an all patients in a group being treated with a medicine or group of medicines. The cohort is selected without bias from all patients being treated with the monitored medicine, and the events include also incidents, not only adverse drug reactions (ADRs)

The specific objectives of this project are to:

  •  Detect signals of unrecognised reactions.
  • Identify interactions with other medicines, complementary and alternative medicines and foods
  • Identify risk factors so that they can be avoided.
  • Assess the safety of ACTs in pregnancy and lactation
  • Provide evidence for effective risk management i.e benefit/harm assessment.

Future projects:

  • Cohort Event Monitoring of Anti-tubercle and antiretroviral medicines in the public sector in Zimbabwe.
  • Post-market surveillance of antiretroviral and anti-tubercle medicines in Zimbabwe.

 

Latest News

Careers @ MCAZ

30 October 2018

GENERAL GRADUATE INTERNS OPPORTUNITY The Medicines Control Authority of Zimbabwe (MCAZ) is inviting applications from hard-working, well-disciplined, honest and self-motivated graduates for a one (1) year general internship opportunity which...

Fellowship in regulatory science for African Medicine Reviewers/Assessors

26 October 2018
Fellowship in regulatory science for African Medicine Reviewers/Assessors

  Background   The Medicines Control Authority of Zimbabwe (MCAZ) Regional Centre of Regulatory Excellence (ReCORE) in partnership with the European and Developing Countries Clinical Trials Partnership (EDCTP) is offering...

Quality Policy Statement

06 July 2018
Quality Policy Statement

The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...

MCAZ Newsletter

10 May 2018
MCAZ Newsletter

In this issue: MCAZ turns 20 years Basics of reporting Side Effects of medicines Electronic Adverse Drug Reaction Reporting   For more information Please click here to download the Newsletter...

Medicines Information Bulletin

02 February 2018
Medicines Information Bulletin

Increased Reporting from the Targeted Spontaneous Reporting (TSR) Programme Click here to download Drug Information Bulletin    

Press Statement on extension of submission of Complementary medicines applications

18 May 2017
Press Statement on extension of submission of Complementary medicines applications

Download Complementary  medicines applications extension - press statement

Zimbabwe National Pharmacovigilance Policy Handbook

12 April 2017
Zimbabwe National Pharmacovigilance Policy Handbook

The aims of the PV policy handbook are to firstly provide a framework for a national pharmacovigilance system in Zimbabwe. Secondly, to define the pharmacovigilance activities undertaken by the Pharmacovigilance...

Scholarship Programme Publicity

14 July 2016
 Scholarship Programme Publicity

The Medicines Control Authority of Zimbabwe (MCAZ) as a responsible corporate citizen runs a Scholarship Fund as part of its corporate social responsibility programmes.   Click here to download the...

Guidelines for Advertising and Promotion of Medicines

24 June 2016
Guidelines for Advertising and Promotion of Medicines

  The approved Guidelines for Advertising and Promotion of Medicines are now available.  Download the Guidelines for Advertising and Promotion of Medicines  

Complementary Medicine Regulation

19 April 2016
Complementary Medicine Regulation

The Medicines Control Authority of Zimbabwe is responsible for the evaluation of safety, efficacy and quality and registration of complementary medicines destined for use in Zimbabwe. Please see the documents...